Michelle van Ryswyk

Michelle van Ryswyk is an experienced professional in clinical operations, currently serving as Associate Director at Cytokinetics since October 2022. Prior roles include Senior Manager in Clinical Operations at Genentech and Global Study Manager, where significant contributions included the successful transition of studies from CROs to sponsors and the development of process documents. Additional experience spans various clinical roles at companies such as Achaogen, Exelixis, Gilead Sciences, Abbott Laboratories, and Allux Medical. Michelle holds a BSc from Trinity Western University and has pursued further education at Stanford University and the British Columbia Institute of Technology.